Chlamydia pneumoniae and occlusive vascular disease: Identification and characterization

Journal of Pharmacological and Toxicological Methods

Volumn 39, Issue 1, 1998, Pages 51-61

  Pai, Jeevan ^a   Knoop, Floyd C ^a   Hunter III, William J ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cell adhesion molecules; Chlamydia pneumoniae; Endothelium; Fibrinogen; IHC; Interferon ; Interleukin 1 ; Occlusive vascular disease; PCR; Restenosis; TEM; Vascular smooth muscle

Indexed keywords

CELL ADHESION MOLECULE; FIBRINOGEN; GAMMA INTERFERON; INTERLEUKIN 1;

ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CHLAMYDOPHILA PNEUMONIAE; ENDOTHELIUM CELL; HUMAN; HYPERPLASIA; LITERATURE; METHODOLOGY; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; RESTENOSIS; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM;

ARTERIAL OCCLUSIVE DISEASES; BLOTTING, SOUTHERN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0031947949     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(98)00002-1     Document Type: Article

References (62)

1. Arno JN, Ricker VA, Butteiger BE, Katz BP, Kane VA, Jones RB. Interferon in endocervical secretions in women infected with Chlamydia trachomatis. J Infect Dis. 162:1990;385-389.
2. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 2:1994;94-98.
3. Campbell L, Melgosa M, Hamilton D, Kuo CC, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol. 30:1992;434-439.
4. Campbell LA, O'Brien ER, Cappuccio AL, Kuo CC, Wang S, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 172:1995;585-588.
5. Cook PJ, Lip GYH, Beevers DG, Wise R, Honeybourne D. Chlamydia pneumoniae and acute arterial thrombotic disease. Circulation. 92:1995;3148-3149.
6. Cook PJ, Lip GYH. Infectious agents and atherosclerotic vascular disease. Q J Med. 89:1996;727-735.
7. Dinarello CA. Interleukin-1 and its biologically related cytokines. Cohen S. Lymphokines and the Immune Response. 1990;145-179 CRC Press, Boca Raton, FL.
8. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 35:1997;48-52.
9. Forsey T, Darouger S, Treharne JD, Jones BR, Herring AJ. Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of Chlamydia. J Infect. 12:1986;145-152.
10. Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Inv Med. 45:1997;168-174.
11. Gaydos CA, Quinn TC, Eiden JJ. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol. 30:1992;796-800.
12. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 64:1996;1614-1620.
13. Godzik KL, O'Brien ER, Wang SK, Kuo CC. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 33:1995;2411-2414.
14. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen Chlamydia pneumoniae strain TWAR . J Infect Dis. 161:1990;618-625.
15. Grayston JT, Kuo CC, Campbell LA, Wang SP. Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR. Int J Syst Bacteriol. 39:1989;88-90.
16. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang S. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 92:1995;3397-3400.
17. Grayston JT, Mordhorst CH, Wang SP. Childhood myocarditis associated with Chlamydia trachomatis infection. JAMA. 246:1981;2823-2827.
18. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis. 15:1992;757-763.
19. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:(2):1997;404-407.
20. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes; ROXIS Pilot Study. ROXIS Study Group. Lancet. 350:1997;404-407.
21. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscl Thromb. 12:1992;945-947.
22. Harlan JM, Harker LA, Striker GE, Weaver LJ. Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res. 29:1983;15-26.
23. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun. 64:1996;4872-4875.
24. Holby N, Doring G, Schiotz PO. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol. 40:1986;29-53.
25. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 176:1997;292-295.
26. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma evaluation of the innocent bystander hypothesis . Am J Pathol. 150:1997;1785-1790.
27. Jang Y, Lincoff AM, Plow E, Topol EJ. Cell adhesion molecules in CAD. JACC. 24:1994;1591-1601.
28. Jones RB, Priest JB, Kuo CC. Subacute chlamydial endocarditis. JAMA. 247:1982;655-658.
29. Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel H, Leinonen M, Kairaluoma M, Saikku P. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 25:1997;499-505.
30. Juvonen J, Laurila A, Juvonen T, Alakarppa H, Surcel HM, Lounatmaa K, Kuusisto J, Saikku P. Detection of Chlamydia pneumoniae in human non-rheumatic stenotic aortic valves. JACC. 29:1997;1054-1059.
31. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M. Chlamydia pneumoniae multiples in human endothelial cells in vitro. Microbiol Path. 16:1994;313-319.
32. Kaukoranta-Tolvanen SS, Ronni T, Leinonen M, Saikku P, Laitinen K. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Path. 21:1996;407-411.
33. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of cytokine response. Microbiol Pathol. 21:1996;215-221.
34. Knoebel E, Vijayagopal P, Figueroa JE, Martin DH. In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun. 65:1997;503-506.
35. Kuo CC, Chen HH, Wang SP, Grayston JT. Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol. 24:1986;1034-1037.
36. Kuo CC, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang SP, Grayston JT. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg. 26:1997;29-31.
37. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterio Thromb. 93:1993;1501-1504.
38. Kuo CC, Shor A, Campbell LA, Fakushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 167:1992;841-849.
39. Kuo CC (1988) In Host response Ed., A Barron. Microbiology of Chlamydia. Boca Raton, FL: CRC Press, pp. 193-208.
40. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aorta of rabbits. Infect Immun. 65:1997;4832-4835.
41. Leinonen M, Linnamaki E, Mattila K, Nieminen MS, Valtonen V, Leirisalo-Repo M, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microbiol Pathogen. 9:1990;67-73.
42. Linnanmaki E, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Valtonen V, et al. Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation. 87:1993;130-134.
43. Marrie TJ, Harczy M, Mann OE, et al. Culture-negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis. 161:1990;127-129.
44. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med. 95:1993;499-504.
45. Miettinen J, Lehto S, Saikku P, Haffner SM, Ronnemaa T, Pyorala K, Laakso M. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J. 17:1996;682-688.
46. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. JACC. 27:1996;1555-1561.
47. Numazaki K, Suzuki K, Chiba S. Replication of Chlamydia trachomatis and Chlamydia pneumoniae in the human monocytic cell line. J Med Microbiol. 42:1995;191-195.
48. Odeh M, Oliven A. Chlamydial infections of the heart. Eur J Clin Microbiol Infect Dis. 11:1992;885-893.
49. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor RD. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 49:1996;102-106.
50. Prescott MF, McBride CK, Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol. 135:1989;835-846.
51. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol. 31:1993;2212-2214.
52. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med. 125:1996;979-982.
53. Richardson M, Roske M, Delaney K, Fletch A, Wilcox LH, Kinlough-Rathbone RL. Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1. Am J Pathol. 151:1997;1009-1017.
54. Saikku P, Leinonen M, Linnanmaki E, Mattila K, et al. Association of immune complexes containing chlamydial lipopolysaccharide with coronary heart disease. Bowie WR, Caldwell HD, Jones RP, et al. Chlamydial Infections. 1990;449-452 Cambridge University Press, Cambridge.
55. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. ii:1988;983-986.
56. Strauss WM. Preparation of genomic DNA from mammalian tissue. Ausubel FM, Brent R, Kingston RE, et al. Current protocols in molecular biology. 1992;2.1.1-2.2.3 Green Publishing Associates and Wiley-Interscience, New York.
57. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 268:1992;68-72.
58. Thom DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 11:1991;547-551.
59. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frakel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 173:1996;957-962.
60. Wynck PB, Brunridge EA. Growth of Chlamydia psittaci in macrophages. Infect Immun. 19:1978;1054-1060.
61. Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis. 171:1995;736-738.
62. Yarnell JWG, Baker IA, Sweetman PM, Bainton PJ, Elwood PC. Fibrinogen, viscocity and white blood cell count are major risk factors for ischaemic heart disease. Circulation. 83:1991;836-844.